J.P. Morgan Comments On BDX's "Mixed" F1Q Results

Becton, Dickinson and Co. BDX reported mixed F1Q results after the close on Monday, J.P. Morgan reports. “On the top line, sales of $1.842B (-1.4% reported, -1.5%cc) came in $46M light of consensus and $27M lower than our own forecast,” J.P. Morgan writes. “On the bottom line, adjusted EPS of $1.35 (+7.8%) was $0.06 above consensus, benefiting from $0.07 of one-off tax items, which were in full-year guidance, but not in guidance or expectations for the first quarter. “Despite the top-line miss and tax benefit, operating performance was otherwise solid this quarter as gross margin of 53.0% was 160bps better than our projection, more than offsetting higher than expected SG&A and R&D spending.” Becton, Dickinson and Co. currently trades at $85.64.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst RatingsBecton Dickinson and Co.Health CareHealth Care EquipmentJ.P. Morgan
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!